These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 16059816

  • 21. Photodynamic therapy for age-related macular degeneration treatment: epidemiological and clinical analysis of a long-term study.
    Mataix J, Desco MC, Palacios E, Garcia-Pous M, Navea A.
    Ophthalmic Surg Lasers Imaging; 2009; 40(3):277-84. PubMed ID: 19485292
    [Abstract] [Full Text] [Related]

  • 22. Deficits in the electroretinogram in neovascular age-related macular degeneration and changes during photodynamic therapy.
    Mackay AM, Brown MC, Hagan RP, Fisher AC, Grierson I, Harding SP.
    Doc Ophthalmol; 2007 Sep; 115(2):69-76. PubMed ID: 17671804
    [Abstract] [Full Text] [Related]

  • 23. Occult with no classic subfoveal choroidal neovascular lesions in age-related macular degeneration: clinically relevant natural history information in larger lesions with good vision from the Verteporfin in Photodynamic Therapy (VIP) Trial: VIP Report No. 4.
    Pieramici DJ, Bressler SB, Koester JM, Bressler NM.
    Arch Ophthalmol; 2006 May; 124(5):660-4. PubMed ID: 16682587
    [Abstract] [Full Text] [Related]

  • 24. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
    Miller JW, Schmidt-Erfurth U, Sickenberg M, Pournaras CJ, Laqua H, Barbazetto I, Zografos L, Piguet B, Donati G, Lane AM, Birngruber R, van den Berg H, Strong A, Manjuris U, Gray T, Fsadni M, Bressler NM, Gragoudas ES.
    Arch Ophthalmol; 1999 Sep; 117(9):1161-73. PubMed ID: 10496388
    [Abstract] [Full Text] [Related]

  • 25. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.
    Retina; 2007 Sep; 27(4):432-8. PubMed ID: 17420694
    [Abstract] [Full Text] [Related]

  • 26. 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.
    Incorvaia C, Campa C, Parmeggiani F, Menzione M, D'Angelo S, Della Corte M, Rinaldi M, Romano M, Dell'omo R, Costagliola C.
    Retina; 2008 Feb; 28(2):289-97. PubMed ID: 18301052
    [Abstract] [Full Text] [Related]

  • 27. A pilot trial for comparison of photodynamic therapy and transpupillary thermotherapy for the management of classic subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Tewari HK, Prakash G, Azad RV, Talwar D, Kai S.
    Indian J Ophthalmol; 2007 Feb; 55(4):277-81. PubMed ID: 17595476
    [Abstract] [Full Text] [Related]

  • 28. Assessment of macular function by multifocal electroretinogram in age-related macular degeneration before and after photodynamic therapy.
    Moschos MM, Panayotidis D, Theodossiadis G, Moschos M.
    J Fr Ophtalmol; 2004 Nov; 27(9 Pt 1):1001-6. PubMed ID: 15557861
    [Abstract] [Full Text] [Related]

  • 29. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.
    Sharp DM, Lai S, Markey CM.
    Clin Exp Ophthalmol; 2007 Nov; 35(1):24-31. PubMed ID: 17300567
    [Abstract] [Full Text] [Related]

  • 30. Multifocal electroretinography as a predictor of maintenance of vision after photodynamic therapy for neovascular age-related macular degeneration.
    Mackay AM, Brown MC, Grierson I, Harding SP.
    Doc Ophthalmol; 2008 Jan; 116(1):13-8. PubMed ID: 17885777
    [Abstract] [Full Text] [Related]

  • 31. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.
    Chaudhary V, Mao A, Hooper PL, Sheidow TG.
    Ophthalmology; 2007 Dec; 114(12):2183-9. PubMed ID: 18054638
    [Abstract] [Full Text] [Related]

  • 32. Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trial.
    Binder S, Krebs I, Hilgers RD, Abri A, Stolba U, Assadoulina A, Kellner L, Stanzel BV, Jahn C, Feichtinger H.
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4151-60. PubMed ID: 15505069
    [Abstract] [Full Text] [Related]

  • 33. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy.
    Ladd BS, Solomon SD, Bressler NM, Bressler SB.
    Am J Ophthalmol; 2001 Nov; 132(5):659-67. PubMed ID: 11704027
    [Abstract] [Full Text] [Related]

  • 34. Dynamics of retinal function after multiple photodynamic therapies in age-related macular degeneration: a report of cases.
    Feigl B, Brown B, Lovie-Kitchin J, Lee L.
    Doc Ophthalmol; 2005 Nov; 111(3):135-48. PubMed ID: 16523231
    [Abstract] [Full Text] [Related]

  • 35. Treatment of neovascular age-related macular degeneration with a variable ranibizumab dosing regimen and one-time reduced-fluence photodynamic therapy: the TORPEDO trial at 2 years.
    Spielberg L, Leys A.
    Graefes Arch Clin Exp Ophthalmol; 2010 Jul; 248(7):943-56. PubMed ID: 20204659
    [Abstract] [Full Text] [Related]

  • 36. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.
    Eandi CM, Ober MD, Freund KB, Slakter JS, Yannuzzi LA.
    Retina; 2007 Sep; 27(7):825-31. PubMed ID: 17891004
    [Abstract] [Full Text] [Related]

  • 37. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.
    Dhalla MS, Shah GK, Blinder KJ, Ryan EH, Mittra RA, Tewari A.
    Retina; 2006 Sep; 26(9):988-93. PubMed ID: 17151484
    [Abstract] [Full Text] [Related]

  • 38. Photodynamic therapy in practice: a review of the results of the first 12 months experience with verteporfin at the Royal Victorian Eye and Ear Hospital.
    Essex RW, Qureshi SH, Cain MS, Harper CA, Guymer RH.
    Clin Exp Ophthalmol; 2003 Dec; 31(6):476-81. PubMed ID: 14641153
    [Abstract] [Full Text] [Related]

  • 39. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
    Gomi F, Ohji M, Sayanagi K, Sawa M, Sakaguchi H, Oshima Y, Ikuno Y, Tano Y.
    Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498
    [Abstract] [Full Text] [Related]

  • 40. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
    Azab M, Boyer DS, Bressler NM, Bressler SB, Cihelkova I, Hao Y, Immonen I, Lim JI, Menchini U, Naor J, Potter MJ, Reaves A, Rosenfeld PJ, Slakter JS, Soucek P, Strong HA, Wenkstern A, Su XY, Yang YC, Visudyne in Minimally Classic Choroidal Neovascularization Study Group.
    Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.